Rg3 inhibits NF-κB and HIF-1α nuclear enrichment by eliminating GEM-induced ROS-mediated Akt activation and ERK signaling, thereby reducing GEM-induced ROS production and the migration and invasion of cancer cells (94). The gene discussed is NFKB1; the disease is cancer.